Intra-Cellular Therapies, Inc. Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc.

ITCI

Ранг среди акций #1690
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on... Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on creating innovative treatments for conditions affecting the brain and nervous system. The company achieves this by targeting the intricate cellular communication pathways within the central nervous system, primarily operating in the United States. Its commercialized product is CAPLYTA, an approved therapy for schizophrenia in adult patients. Furthermore, the company maintains a robust development pipeline, including lumateperone, which is undergoing late-stage (Phase III) clinical trials for bipolar depression and is also being investigated for autism spectrum disorder and various sleep disturbances associated with neuropsychiatric and neurological illnesses. Other key drug candidates in its pipeline include Lenrispodun (ITI-214), aimed at treating Parkinson's disease and heart failure; ITI-1284-ODT-SL, designed to address neuropsychiatric disorders and behavioral challenges in dementia; and ITI-333, intended for substance use disorders, pain management, and co-occurring psychiatric conditions like depression and anxiety. Established in 2002, Intra-Cellular Therapies, Inc. has its headquarters situated in New York, New York.
Цена акции
$131.87
Последняя синхронизация: 2025-04-02
Рыночная капитализация
$12.68B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Intra-Cellular Therapies, Inc. (ITCI)

Категория

Healthcare
Количество находящихся в обращении акций Intra-Cellular Therapies, Inc. (ITCI)
Количество акций в обращении на December 2024: 103.13M
Согласно последним финансовым отчетам и цене акций Intra-Cellular Therapies, Inc., текущее количество акций в обращении составляет 103.13M. На конец December 2023 у компании было 95.88M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Intra-Cellular Therapies, Inc. (ITCI) с 2013 по 2026
Акции в обращении на конец каждого года
Год Акции в обращении Изменить
2026 (TTM) 103.13M 0.00%
2024 103.13M 7.56%
2023 95.88M 1.95%
2022 94.05M 15.74%
2021 81.25M 15.47%
2020 70.36M 27.50%
2019 55.19M 0.87%
2018 54.71M 18.46%
2017 46.18M 6.80%
2016 43.24M 20.07%
2015 36.01M 25.69%
2014 28.65M 66.35%
2013 17.22M 0.00%
Акции в обращении у аналогичных компаний или конкурентов
Компания Акции в обращении Разница Страна
- -
DE
- -
DE
- -
JP
- -
CH
2.40B 2,226.49%
IN